NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 59.32

+2.3%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	7/26/2007 3:11:34 PM
	Read Replies (2) of 507

Tuck, From Briefing (I no longer follow NKTR) so there's probably a company issued PR... The first peer-reviewed preclinical and early Phase 1 clinical data for Nektar Therapeutics' (NKTR) proprietary product candidate, NKTR-118 are scheduled to be presented at two upcoming scientific meetings...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next